29.07.2011 • NewsH1 2011Lindesales and profits

Linde H1 Earnings Up

Linde Group's six-month earnings attributable to Linde AG shareholders after adjusting for non-controlling interests advanced to €566 million from €445 million last year. Earnings after tax rose 23.8% to €598 million from €483 million a year ago.

In the first half of 2011, group sales improved 11% to €6.77 billion from €6.10 billion in the comparable period a year ago. After adjusting for exchange rate effects, the increase in sales was 10.3%.

Earnings per share grew by 26.2% to €3.32 from €2.63 a year earlier. On an adjusted basis, after adjusting for the effects of the purchase price allocation from the 2006 BOC acquisition, earnings per share stood at €3.79 compared with €3.15 in 2010.

The company confirmed its outlook and expects to achieve growth in group sales and group operating profit in the 2011 financial year compared with the prior year.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.